logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US RE48345 B1

PDFFull Text
Date of Patent:
Dec. 07, 2020

Filed:

Aug. 18, 2016

Compositions and methods for inhibiting gene expression of hepatitis b virus

Applicant:

Arrowhead Pharmaceuticals, Inc., Pasadena, CA (US);

Inventors:

Daniel J. Chin, Foster City, CA (US);

Jochen Deckert, Kulmbach, DE;

Markus Hossbach, Kulmbach, DE;

Matthias John, Hallstadt, DE;

Assignee:

Arrowhead Pharmaceuticals Inc., Pasadena, CA (US);

Attorney:

Morrison & Foerster LLP

Primary Examiner:

Bruce R Cambell

Int. Cl.
CPC ...
C12N 15/11 (2005.12); A61K 48/00 (2005.12); C07H 21/02 (2005.12); C07H 21/04 (2005.12); A61K 31/713 (2005.12); C12N 15/113 (2009.12);
U.S. Cl.
CPC ...
A61K 31/713 (2012.12); C12N 15/1131 (2012.12); C12N 2310/14 (2012.12); C12N 2310/315 (2012.12); C12N 2310/321 (2012.12); C12N 2310/335 (2012.12); C12N 2310/3521 (2012.12);
Abstract

The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a Hepatitis B Virus gene. The invention also relates to a pharmaceutical composition comprising the dsRNA or nucleic acid molecules or vectors encoding the same together with a pharmaceutically acceptable carrier; methods for treating diseases caused by Hepatitis B Virus infection using said pharmaceutical composition; and methods for inhibiting the expression of a Hepatitis B Virus gene in a cell.

Find Patent Forward Citations

Chin, Daniel. (2020). Compositions and methods for inhibiting gene expression of hepatitis b virus (U.S. Patent No. RE48345). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/RE48345

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…